Michael J. Pederson
Corporate Officer/Principal bij Abbott Ltd.
Vermogen: 7 M $ op 30-04-2024
Profiel
Michael J.
Pederson is currently working as a Finance Manager-Licensing & Acquisitions at Abbott Ltd.
Prior to this, he worked as the Chief Executive Officer at Vytronus, Inc. and as an Independent Director at EPIX Therapeutics, Inc.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ABBOTT LABORATORIES
0.00% | 28-02-2023 | 63 231 ( 0.00% ) | 7 M $ | 30-04-2024 |
Actieve functies van Michael J. Pederson
| Bedrijven | Functie | Begin |
|---|---|---|
| Abbott Ltd. | Corporate Officer/Principal | - |
Eerdere bekende functies van Michael J. Pederson
| Bedrijven | Functie | Einde |
|---|---|---|
Vytronus, Inc.
 Vytronus, Inc. Medical SpecialtiesHealth Technology VytronUS, Inc. develops imaging and therapeutic capabilities of ultrasound energy to treat cardiac arrhythmias. The firm develops a catheter-based ablation platform based on low-intensity collimated ultrasound (LICU) which allows for precise non-contact energy delivery and producing high-resolution maps of cardiac anatomy. The company was founded by Hira V. Thapliyal in 2006 and is headquartered in Sunnyvale, CA. | Algemeen Directeur | 06-04-2015 |
EPIX Therapeutics, Inc.
 EPIX Therapeutics, Inc. Electronic Equipment/InstrumentsElectronic Technology EPIX Therapeutics, Inc. operates as a medical device company that designs and manufactures catheter-based systems. It offers irrigated radiofrequency ablation catheters for atrial fibrillation. The company was founded by Kenneth Carr, Peter van der Sluis, Eric Kanowsky and Timothy J. Lenihan in 2007 and is headquartered in Santa Clara, CA. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Vytronus, Inc.
Vytronus, Inc. Medical SpecialtiesHealth Technology VytronUS, Inc. develops imaging and therapeutic capabilities of ultrasound energy to treat cardiac arrhythmias. The firm develops a catheter-based ablation platform based on low-intensity collimated ultrasound (LICU) which allows for precise non-contact energy delivery and producing high-resolution maps of cardiac anatomy. The company was founded by Hira V. Thapliyal in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
EPIX Therapeutics, Inc.
EPIX Therapeutics, Inc. Electronic Equipment/InstrumentsElectronic Technology EPIX Therapeutics, Inc. operates as a medical device company that designs and manufactures catheter-based systems. It offers irrigated radiofrequency ablation catheters for atrial fibrillation. The company was founded by Kenneth Carr, Peter van der Sluis, Eric Kanowsky and Timothy J. Lenihan in 2007 and is headquartered in Santa Clara, CA. | Electronic Technology |
| Abbott Ltd. |
